Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-977-3 | CAS number: 7783-06-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Human exposure to exogenous hydrogen sulfide is principally via inhalation, and the gas is rapidly absorbed through the lungs. Hydrogen sulfide is metabolized through three pathways: oxidation, methylation, and reactions with metalloproteins or disulfide-containing proteins. Oxidation in the liver is the major detoxification pathway. The major oxidation product is thiosulfate, which is then converted to sulfate and excreted in the urine. The methylation pathway also serves as a detoxification route. The toxicity of hydrogen sulfide is a result of its reaction with metalloenzymes. In the mitochondria, cytochrome oxidase, the final enzyme in the respiratory chain, is inhibited by hydrogen sulfide; this disrupts the electron transport chain and impairs oxidative metabolism. Nervous and cardiac tissues, which have the highest oxygen demand, are especially sensitive to the disruption of oxidative metabolism. In the central nervous system, this effect may result in death from respiratory arrest (WHO, 2003).
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
As summarized in the Concise International Chemical Assessment Document #53 (WHO, 2003).
Inhalation is the most common route of exogenous hydrogen sulfide exposure. Hydrogen sulfide is rapidly absorbed through the lungs in humans. It can also be absorbed through the gastrointestinal tract (ATSDR, 1999). At physiological pH, hydrogen sulfide is dissociated to the hydrogen sulfide anion in the circulation, which is probably the absorbed form (WHO, 2000). In animals, absorption of hydrogen sulfide via the lungs also occurs readily and rapidly (Beck et al., 1979; Khan et al., 1990; Kage et al., 1992). The distribution of inhaled hydrogen sulfide is rapid and widespread; storage of hydrogen sulfide in the body is limited by rapid metabolism and excretion (Nagata et al., 1990). Male Wistar rats exposed through an inhaler to hydrogen sulfide at 110 mg/m3for 20, 40, or 60 min showed essentially the same ratios of distribution of hydrogen sulfide, irrespective of duration. The hydrogen sulfide concentration was highest in the heart, and the level in brain was comparable to the levels in lung, liver, kidney, and spleen. The tissue levels after 20 min of exposure were 10 µg/ml in blood, 25 µg/g in brain, 20 µg/g in lung, 37 µg/g in heart, 20 µg/g in liver, 25 µg/g in spleen, and 30 µg/g in kidney (Kohno et al., 1991). Hydrogen sulfide levels of 0.92 µg/g in blood, 1.06 µg/g in brain, 0.34 µg/g in kidney, and 0.38 µg/g in liver were detected at autopsy in a man who was overcome by hydrogen sulfide after working for 5 min in a tank (Winek et al., 1968). Hydrogen sulfide concentrations in the tank after the accident were 2700–8500 mg/m3.
Hydrogen sulfide is metabolized through three pathways: oxidation, methylation, and reactions with metalloproteins or disulfide-containing proteins (Beauchamp et al., 1984). The major metabolic pathway for detoxification of hydrogen sulfide is oxidation in the liver; the major oxidation product of sulfide is thiosulfate, which is then converted to sulfate and subsequently excreted in urine (Bartholomew et al., 1980). The methylation pathway also serves as a detoxification route (Weisiger & Jacoby, 1980; US EPA, 1987). Reaction with metalloproteins is a major mechanism of toxicity of hydrogen sulfide. Hydrogen also reduces disulfide bridges in proteins. Oxidized glutathione protects against hydrogen sulfide poisoning. Hydrogen sulfide is excreted primarily as sulfate (free sulfate or thiosulfate) in the urine. It is also excreted unchanged in exhaled air and in faeces and flatus. Thiosulfate in urine is a useful indicator of hydrogen sulfide exposure (Kage et al., 1997). Thiosulfate excretion was measured in volunteers exposed to 11, 25, or 42 mg hydrogen sulfide/m3for 30–45 min and compared with that of unexposed individuals at a pelt processing plant (Kangas & Savolainen, 1987). The study did not report the summary results of all exposed individuals; however, data from one individual exposed to 25 mg hydrogen sulfide/m3for 30 min found urinary thiosulfate concentrations of approximately 2, 4, 7, 50, and 5 mmol/mol creatinine at 1, 2, 5, 15, and 17 h post-exposure, respectively. Urinary thiosulfate excreted in controls was 2.9 ± 2.5 (standard deviation [SD]) mmol/mol creatinine (n= 29). In this one individual, therefore, the highest urinary thiosulfate level occurred 15 h after exposure and dropped to control levels by 17 h post-exposure; most absorbed hydrogen sulfide was already oxidized by 15 h post-exposure. The delayed oxidation product thiosulfate buildup is consistent with the metabolic pathway of hydrogen sulfide, which included at least two oxidation steps (Beauchamp et al., 1984).
Evidence for the methylation of hydrogen sulfide comes primarily from in vitro studies of Sprague-Dawley rat intestinal mucosa (Weisiger et al., 1980). Thiol S-methyltransferase catalysed the methylation of hydrogen sulfide to methanethiol (CH3SH). Methanethiol can act as a substrate for another methylation that is also catalysed by thiol S-methyltransferase, yielding dimethylsulfide (CH3SCH3) (Weisiger & Jacoby, 1980; US EPA, 1987). The activity of thiol S-methyltransferase was widely distributed, with the greatest activity being found in the caecal and colonic mucosa, liver, lung, and kidney; enzyme activity was also found in other parts of the intestine and stomach, spleen, heart, and skeletal muscle. No enzyme activity was found in the faeces. Although it has been postulated that methylation is a method of detoxification of hydrogen sulfide, a constituent of human flatus produced in the intestine, the extent to which the toxicity of exogenous hydrogen sulfide is attenuated by methylation is not known.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.